The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment.
Patrick M
PM
Honore
Rita
R
Jacobs
Elisabeth
E
De Waele
Viola
V
Van Gorp
Herbert D
HD
Spapen
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016638:Critical Illness / Q000628:therapy*; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008911:Minocycline / Q000031:analogs & derivatives*; D012720:Severity of Illness Index
D000900:Anti-Bacterial Agents; D008911:Minocycline